BioHarvest Sciences Inc. Common Stock (BHST)

• Market cap: $101M
• 1 day: -1.19%
• 5 days: -3.64%
• 1 month: -5.82%
• 3 months: -0.34%
• 6 months: -0.34%
• Year to date: -4.74%
• 1 year: -0.34%
• 5 years: -0.34%
• 10 years: -0.34%

About: BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 106% upside
• Avg. target: $13 123% upside
• High target: $14 140% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Anthony Vendetti 0 / 0 met price target	106% upside $12	Buy Initiated	18 Dec 2024
HC Wainwright & Co. Amit Dayal 0 / 0 met price target	140% upside $14	Buy Reiterated	11 Dec 2024